Clinical Trials
- Heart/Cardiovascular
TARGET BP I Clinical Trial (TARGET BP I)
- Ages18 years - 80 years
- GenderBoth
- Heart/Cardiovascular
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature (ELEGANCE)
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
DEFIANCE: Randomized Clinical Trial of ClotTriever system versus anticoagulation in Deep Vein Thrombosis
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Genomic Basis of Neurodevelopmental and Brain Outcomes in Congenital Heart Disease (CHD Brain and Genes)
- Ages8 years and older
- GenderBoth
- Heart/Cardiovascular
The Recovery in Stroke Using PAP Study (RISE-UP)
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
The HYDRATION Study
- Heart/Cardiovascular
Medtronic Product Surveillance Registry
- Heart/Cardiovascular
SCOPE-CLI: Shifting Care and Outcomes for Patients with Endangered limbs Critical Limb Ischemia
- Ages19 years and older
- GenderBoth
- Heart/Cardiovascular
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3